Dr Ednah Ooko

placeholder-732.png

Dr Ednah Ooko

PRINCIPAL INVESTIGATOR

RESEARCH GROUPS:

Biography

I attained my PhD in Mainz Germany in 2017 where I was understanding the genomics of multidrug resistance in a broad spectrum of cancer cells.  The role of P-glycoprotein was key to this understanding. This was then followed by a postdoctoral experience at the National Institute of Health, National Cancer Institute, Bethesda Maryland, USA where I worked on the CRISPAR techniques in understanding multidrug resistance genomics in ovarian, uterine and Breast cancer. 

I am currently at Early research fellow working on antimicrobial resistance (AMR) in Kilifi Kenya where I am focusing on bacterial genomics and the role of the microbiome in carriage of ESBL-Es.

Links

I am currently at Early research fellow working on antimicrobial resistance (AMR) in Kilifi Kenya where I am focusing on bacterial genomics and the role of the microbiome in carriage of ESBL-Es. 

To this point we are focussing on community acquired and carriage of ESBL-E and as of now we are on the early phases of the research.  Internal collaborators include Prof. Jay Berkley, Prof Philip Bejon, Dr. James Njunge and Dr. Sam Akech.  For external collaborators we have Dr. Nicole Stoesser and Dr. Rosie Crane. 

We hope to clearly document the evolution of AMR in Kenya and give a clear position on where we are on AMR currently including the resistance markers circulating in our community and which drugs we can apply to avoid or reduce the problem of antibiotic drug resistance.